Evidence map›Paper›PMID 30448061›Full record

ArticleBiochemical and biophysical research communications2018

Dll4-Notch1 signaling but not VEGF-A is essential for hyperoxia induced vessel regression in retina.

Guofu Zhu, Ying Lin, Hao Liu, Dongyang Jiang, Shekhar Singh, Xiankai Li, Ze Yu, Linlin Fan, Shumin Wang, Jordan Rhen and 4 more

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Guofu ZhuDepartment of Cardiology, Pan-Vascular Research Institute of Tongji University, Shanghai Tenth People's Hospital, Tongji University School of Medicine, China.
Ying LinDepartment of Cardiology, Pan-Vascular Research Institute of Tongji University, Shanghai Tenth People's Hospital, Tongji University School of Medicine, China.
Hao LiuDepartment of Cardiology, Pan-Vascular Research Institute of Tongji University, Shanghai Tenth People's Hospital, Tongji University School of Medicine, China.
Dongyang JiangDepartment of Cardiology, Pan-Vascular Research Institute of Tongji University, Shanghai Tenth People's Hospital, Tongji University School of Medicine, China.
Shekhar SinghDepartment of Cardiology, Pan-Vascular Research Institute of Tongji University, Shanghai Tenth People's Hospital, Tongji University School of Medicine, China.
Xiankai LiDepartment of Cardiology, Pan-Vascular Research Institute of Tongji University, Shanghai Tenth People's Hospital, Tongji University School of Medicine, China.
Ze YuCollege of Laboratory Science, Dalian Medical University, Dalian, China.
Linlin FanCollege of Laboratory Science, Dalian Medical University, Dalian, China.
Shumin WangAab Cardiovascular Research Institute and Department of Medicine, University of Rochester, School of Medicine and Dentistry, Rochester, NY, USEA.
Jordan RhenAab Cardiovascular Research Institute and Department of Medicine, University of Rochester, School of Medicine and Dentistry, Rochester, NY, USEA.
Weiming LiDepartment of Cardiology, Pan-Vascular Research Institute of Tongji University, Shanghai Tenth People's Hospital, Tongji University School of Medicine, China.
Yawei XuDepartment of Cardiology, Pan-Vascular Research Institute of Tongji University, Shanghai Tenth People's Hospital, Tongji University School of Medicine, China.
Junbo GeDepartment of Cardiology, Pan-Vascular Research Institute of Tongji University, Shanghai Tenth People's Hospital, Tongji University School of Medicine, China. Electronic address: jbge@zs-hospital.sh.cn.
Jinjiang PangDepartment of Cardiology, Pan-Vascular Research Institute of Tongji University, Shanghai Tenth People's Hospital, Tongji University School of Medicine, China; Aab Cardiovascular Research Institute and Department of Medicine, University of Rochester, School of Medicine and Dentistry, Rochester, NY, USEA. Electronic address: Jinjiang_pang@URMC.rochester.edu.
Tongji University · CNDalian Medical University · CNUniversity of Rochester · US

Funding

The novel mechanisms of HIV associated vascular cognitive impairmentR01HL122777 · NHLBI · UNIVERSITY OF ROCHESTER · PI PANG, JINJIANG · 2014 to 2023
$4.1M
NHLBI NIH HHS R01 HL122777
6 · The paper itself

Abstract

It is well recognized that decreased vascular endothelial growth factor A (VEGF-A) mRNA plays an important role in retinal vessel regression induced by hyperoxia. However, this concept has been challenged by increasing new evidence. Furthermore, VEGF-A strongly enhances Dll4 expression and inhibition of Dll4-Notch signaling leads to excessive sprouting angiogenesis. Recently, it is shown that inactivation of Dll4-Notch1 signaling reduce hyperoxia induced vessel regression. It is unknown whether sprouting angiogenesis contributes to the protective effect or not and further investigations are needed. Moreover, the expression of Dll4 or Notch1 activation in the regressing plexus remains elucidated. To determine the role of VEGF-A and Dll4-Notch1 signaling in hyperoxia induced vascular regression in the retina, we used mice at postnatal day 5 (P5) - P7. Hyperoxia induced massive vascular regression in the central plexus but not in the angiogenic plexus and had no effect on sprouting angiogenesis. Immunostaining showed that VEGF-A was significantly repressed in the angiogenic front region after hyperoxia exposure but not detectable in the central area of both normoxia and hyperoxia treated retinas. In contrast, Notch ligand Delta-like 4 (Dll4) and Notch1 intracellular domain (N1-ICD) expression were inhibited in the regressing capillaries of central retina but comparable in the angiogenic plexus after high oxygen treatment. Moreover, administration of Dll4 neutralizing antibody or γ-Secretase inhibitor DAPT significantly aggravated vessel regression induced by short-time hyperoxia administration. Our data show that repressed Dll4-Notch1 signaling pathway but not downregulation of VEGF-A expression are responsible for hyperoxia induced pervasive vessel regression.

Indexed as

Signal TransductionAdaptor Proteins, Signal TransducingAnimalsAnimals, NewbornCalcium-Binding ProteinsHyperoxiaIntracellular Signaling Peptides and ProteinsMembrane ProteinsMiceNeovascularization, PhysiologicReceptor, Notch1RetinaVascular Endothelial Growth Factor AAdaptor Proteins, Signal TransducingCalcium-Binding ProteinsDLL4 protein, mouseIntracellular Signaling Peptides and ProteinsMembrane ProteinsReceptor, Notch1Vascular Endothelial Growth Factor ADelta-like 4HyperoxiaNotch1Vascular endothelial growth factor AVessel regression

Identifiers

PMID30448061
PMCPMC8634547
OpenAlexW2901346636

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.